NeoGenomics, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents
NeoGenomics, Inc. (NEO) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents of $890.00 thousand as of 2015-12-30, per its 10-Q filed 2016-11-07.
Discontinued › Notes
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents · last filed 2016-11-07
- 2015-12-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents $890.00K.
- 2014-07-08: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents $79.00K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents |
|---|---|
| 2015-12-30 | $890.00K 10-Q · filed 2016-11-07 |
| 2014-07-08 | $79.00K 10-K · filed 2016-04-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |